Global Digital Breast Tomosynthesis Market 2014-2018

Global Digital Breast Tomosynthesis Market 2014-2018 is the new research report added to store.

Repost This

Dallas, TX -- (SBWIRE) -- 12/16/2013 -- The use of DBT to diagnose breast cancer in patients with dense breasts is an emerging trend in the Global DBT market. Although mammography still remains the best imaging technique for detecting breast cancer, it can fail to detect 37-70 percent of breast cancer cases in women with dense breasts. As a result, there can be a delay in diagnosis for women with dense breast tissues. DBT enables the removal of overlapping tissue artifacts, especially in dense breasts, and offers better screening sensitivity. Thus, increased use of DBT for patients with dense breasts will fuel the demand for DBT equipment in the Diagnostic industry.

The Global Digital Breast Tomography Market 2014-2018 ( with a CAGR of 18.57 percent for the period 2013-2018. According to the report, one of the main drivers in this market is the increase in the incidence of breast cancer among women, which has led to an increase in demand for imaging equipment such as breast tomosynthesis devices.

Analysts use a unique methodology to scrutinize individual vendor performance, trends, drivers and challenges, and a number of other factors to provide the most accurate and detailed market research reports possible.

A more specific breakdown of this report's contents is below.

Overview of market share and landscape for the following key geographies:
?North America
Overview and impact analysis of:
- ?3 Market Drivers
- ?3 Market Challenges
- ?3 Market Trends

Market Shares and SWOT Analysis for these vendors:
- ?Hologic Inc.
- ?GE Healthcare
- ?Internazionale Medico Scientifica Srl
- ?Siemens Healthcare

Buy a copy of report @

Five Force Model Impact Analysis of:
- ?Suppliers
- ?Buyers
- ?Substitutes
- ?New entrants
- ?Market competition

The report recognizes the following companies as the key players in the Global Digital Breast Tomosynthesis Market: GE Healthcare, Hologic Inc., Internazionale Medico Scientifica Srl, and Siemens Healthcare.

Further, the report states that one of the major challenges faced by the market is the lack of reimbursement policies for breast imaging through DBT for breast cancer diagnosis.